Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers

被引：24
|
作者：
Zhang, Xiaoli [1 ]
Pan, Zui [2 ]
机构：
[1] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43201 USA
[2] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76010 USA
来源：
GASTROENTEROLOGY REPORT | 2020年 / 8卷 / 03期
基金：
美国国家卫生研究院;
关键词：
dysbiosis; tumor microenvironment; proton-pump inhibitors; antibiotics; checkpoint inhibitors; H; pylori; HELICOBACTER-PYLORI; MOLECULAR CHARACTERIZATION; INTESTINAL METAPLASIA; BACTERIAL BIOTA; GUT MICROBIOME; RISK; INFLAMMATION; THERAPY; EFFICACY; STOMACH;
D O I：
10.1093/gastro/goaa014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Gastric and esophageal cancers are multifactorial and multistage-involved malignancy. While the impact of gut microbiota on overall human health and diseases has been well documented, the influence of gastric and esophageal microbiota on gastric and esophageal cancers remains unclear. This review will discuss the reported alteration in the composition of gastric and esophageal microbiota in normal and disease conditions, and the potential role of dysbiosis in carcinogenesis and tumorigenesis. This review will also discuss how dysbiosis stimulates local and systemic immunity, which may impact on the immunotherapy for cancer.
引用
收藏
页码：206 / 214
页数：9
相关论文
共 50 条
  • [21] Immunotherapy-responsive gastric cancers identified
    Peter Sidaway
    Nature Reviews Gastroenterology & Hepatology, 2018, 15 : 582 - 582
  • [22] Immunotherapy-responsive gastric cancers identified
    Sidaway, Peter
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (10) : 582 - 582
  • [23] Tumor Immunity and Immunotherapy for HPV-Related Cancers
    Shamseddine, Achraf A.
    Burman, Bharat
    Lee, Nancy Y.
    Zamarin, Dmitriy
    Riaz, Nadeem
    CANCER DISCOVERY, 2021, 11 (08) : 1896 - 1912
  • [24] Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?
    Puhr, Hannah Christina
    Preusser, Matthias
    Ilhan-Mutlu, Ayseguel
    CANCERS, 2021, 13 (18)
  • [25] What’s New in Gastric and Esophageal Cancers
    Kenneth Tanabe
    Annals of Surgical Oncology, 2016, 23 : 3773 - 3773
  • [26] DOUBLE ESOPHAGEAL OF ESOPHAGO-GASTRIC CANCERS
    EDELMANN, G
    LANGRAND, L
    ANNALES DE CHIRURGIE, 1973, 27 (03): : 254 - 256
  • [27] The Molecular Biologic Basis of Esophageal and Gastric Cancers
    Pennathur, Arjun
    Godfrey, Tony E.
    Luketich, James D.
    SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (03) : 403 - +
  • [28] Simultaneous Resection of Synchronous Esophageal and Gastric Cancers
    Park, Byungjoon
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Zo, Jae Il
    Shim, Young Mog
    THORACIC AND CARDIOVASCULAR SURGEON, 2016, 64 (07): : 611 - 618
  • [29] ABO genotypes and the risk of esophageal and gastric cancers
    Chen, Yingxi
    Hu, Nan
    Liao, Linda
    Yu, Kai
    Shu, Xiao-Ou
    Zheng, Wei
    Yuan, Jian-Min
    Koh, Woon-Puay
    Qiao, You-Lin
    Fan, Jin-Hu
    Dawsey, Sanford M.
    Freedman, Neal D.
    Taylor, Philip R.
    Goldstein, Alisa M.
    Abnet, Christian C.
    BMC CANCER, 2021, 21 (01)
  • [30] Population attributable risks of esophageal and gastric cancers
    Engel, LS
    Chow, WH
    Vaughan, TL
    Gammon, MD
    Risch, HA
    Stanford, JL
    Schoenberg, JB
    Mayne, ST
    Dubrow, R
    Rotterdam, H
    West, AB
    Blaser, M
    Blot, WJ
    Gail, MH
    Fraumeni, JF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) : 1404 - 1413
12345